中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
  2. 上海药物研究所
  3. 中国科学院上海药物研究所
Structural insights into the activation of GLP-1R by a small molecule agonist

文献类型：期刊论文

作者Ma, Honglei1; Huang, Wei3; Wang, Xiaoxi1; Zhao, Lihua1; Jiang, Yi1; Liu, Feng2; Guo, Wei; Sun, Xianqiang3; Zhong, Wenge3; Yuan, Daopeng3
刊名CELL RESEARCH
出版日期2020-07-28
页码3
ISSN号1001-0602
DOI10.1038/s41422-020-0384-8
通讯作者Yuan, Daopeng(Daopeng.yuan@qlregor.com) ; Xu, H. Eric(Eric.xu@simm.ac.cn)
WOS关键词GLUCAGON-LIKE PEPTIDE-1 ; CRYO-EM STRUCTURE ; RECEPTOR
资助项目Ministry of Science and Technology (China)[2018YFA0507002] ; Shanghai Municipal Science and Technology Major Project[2019SHZDZX02] ; CAS Strategic Priority Research Program[XDB08020303] ; Shanghai Science and Technology Committee[19ZR1467500] ; Young Innovator Association of CAS[2018325] ; SA-SIBS Scholarship Program ; National Natural Science Foundation of China[31770796] ; National Science & Technology Major Project Key New Drug Creation and Manufacturing Program[2018ZX09711002] ; K.C. Wong Education Foundation
WOS研究方向Cell Biology
语种英语
WOS记录号WOS:000553324500002
出版者NATURE PUBLISHING GROUP
源URL[http://119.78.100.183/handle/2S10ELR8/292184]  
专题中国科学院上海药物研究所
通讯作者Yuan, Daopeng; Xu, H. Eric
作者单位1.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China
2.Regor Pharmaceut Inc, 50 Soldiers Field Pl, Boston, MA 02135 USA
3.Qilu Regor Therapeut Inc, 1206 Zhangjiang Rd,Bldg C, Shanghai 201210, Peoples R China
推荐引用方式
GB/T 7714		 Ma, Honglei,Huang, Wei,Wang, Xiaoxi,et al. Structural insights into the activation of GLP-1R by a small molecule agonist[J]. CELL RESEARCH,2020:3.
APA Ma, Honglei.,Huang, Wei.,Wang, Xiaoxi.,Zhao, Lihua.,Jiang, Yi.,...&Xu, H. Eric.(2020).Structural insights into the activation of GLP-1R by a small molecule agonist.CELL RESEARCH,3.
MLA Ma, Honglei,et al."Structural insights into the activation of GLP-1R by a small molecule agonist".CELL RESEARCH (2020):3.

入库方式： OAI收割

来源：上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。